Back
Back

iShares Healthcare Innovation

Global healthcare companies

(DRDR)
£6.16
Previous business day’s close price
‑£1.34 (‑17.89%)
max available period
£5
£8.14
04 Jan 21
22 Nov 24

Details

ETF description

The iShares Healthcare Innovation ETF is designed to provide investors with exposure to companies that are at the forefront of technological advancements and innovation within the healthcare sector. By tracking the NYSE FactSet Global Healthcare Innovators index, this ETF focuses on firms involved in pioneering medical technologies, biotechnology, pharmaceuticals, and healthcare services, aiming to capture the growth potential from the latest advancements in healthcare.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The Healthcare Innovation index offers specialized exposure to companies that are leading the way in healthcare advancements and breakthroughs. By focusing on innovative technologies, treatments, and solutions, the index aims to deliver growth potential and investment opportunities driven by the latest trends in healthcare. It serves as a valuable tool for investors seeking to capitalize on the transformative impact of healthcare innovation while benefiting from diversified exposure to cutting‑edge developments in the sector.

This ETF is in collections:

Thematics
Healthcare

Key information

Key investor information

ETF Breakdown

Region
Sector
argenx SE
2.3%
Gilead Sciences, Inc.
2.0%
UCB SA
2.0%
Illumina Inc
2.0%
Bristol‑Myers Squibb Co.
1.9%
Insulet Corporation
1.8%
Intuitive Surgical Inc
1.8%
Abbvie Inc
1.7%
Samsung Biologics Co Ltd
1.6%
Lonza Group AG
1.6%
Exact Sciences Corp.
1.6%
Abbott Laboratories
1.6%
Boston Scientific Corp.
1.6%
Natera Inc
1.6%
Medtronic Plc
1.6%
Johnson & Johnson
1.6%
Hologic, Inc.
1.6%
AMGEN Inc.
1.5%
Agilent Technologies Inc.
1.5%
Novartis AG
1.5%
Sarepta Therapeutics Inc
1.5%
Bio‑Techne Corp
1.4%
Pfizer Inc.
1.4%
IQVIA
1.4%
BeiGene Ltd
1.4%
Thermo Fisher
1.4%
Celltrion Inc
1.4%
Danaher Corp.
1.4%
Exelixis Inc
1.3%
Catalent Inc.
1.3%
Neurocrine Biosciences, Inc.
1.3%
GSK Plc
1.3%
Qiagen N.V.
1.2%
Sysmex Corporation
1.2%
Charles River Laboratories International Inc.
1.2%
Genmab
1.2%
Revolution Medicines Inc
1.1%
Biogen Inc
1.1%
Eisai Co Ltd
1.1%
Merck & Co Inc
1.1%
Shimadzu Corporation
1.1%
Edwards Lifesciences Corp
1.1%
Bio‑Rad Laboratories Inc.
1.0%
Intra‑Cellular Therapies Inc
1.0%
Lantheus Holdings Inc
1.0%
Halozyme Therapeutics Inc.
1.0%
Repligen Corp.
0.9%
Medpace Holdings Inc
0.9%
Pro Medicus
0.9%
Dexcom Inc
0.8%
Zealand Pharma A/S.
0.8%
Sartorius AG
0.8%
Ionis Pharmaceuticals Inc
0.7%
Biomerieux
0.7%
Maximus Inc.
0.7%
Siegfried Holding AG
0.6%
Alkermes plc
0.6%
Ipsen
0.6%
Moderna Inc
0.5%
Asahi Intecc Co. Ltd.
0.5%
Akeso Inc
0.5%
Sectra Class B
0.5%
BridgeBio Pharma Inc
0.5%
TG Therapeutics Inc
0.5%
Denali Therapeutics Inc
0.4%
Axonics Inc
0.4%
Axsome Therapeutics Inc
0.4%
Tecan Group AG
0.4%
Corvel Corp.
0.4%
Neogen Corp.
0.4%
PTC Therapeutics Inc
0.4%
Rhythm Pharmaceuticals Inc.
0.4%
Diasorin S.p.A.
0.4%
Arcellx Inc
0.4%
Guardant Health Inc
0.3%
R1 Rcm Inc
0.3%
Bachem Holding AG
0.3%
LivaNova PLC
0.3%
Merus N.V
0.3%
Catalyst Pharmaceuticals Inc
0.3%
Lion Biotechnologies Inc
0.3%
Veracyte Inc
0.3%
Evolent Health Inc
0.3%
SK Biopharmaceuticals Co. Ltd.
0.3%
Bavarian Nordic A/S
0.3%
Geron Corp.
0.3%
Twist Bioscience Corp
0.3%
Apollo Medical Holdings Inc
0.3%
Elekta AB (publ)
0.3%
Ideaya Biosciences Inc
0.3%
Tandem Diabetes Care Inc
0.3%
HUTCHMED (China) Limited
0.3%
JEOL Ltd.
0.3%
Ligand Pharmaceuticals, Inc.
0.2%
Nurix Therapeutics Inc
0.2%
QuidelOrtho Corporation
0.2%
Supernus Pharmaceuticals Inc
0.2%
Acadia Pharmaceuticals Inc
0.2%
10x Genomics Inc
0.2%
H. Lundbeck AS
0.2%
Sawai Group Holdings Co Ltd
0.2%
Arvinas Operations Inc
0.2%
Atricure Inc
0.2%
Beam Therapeutics Inc
0.2%
Integra Lifesciences Holdings Corp
0.2%
NovoCure Ltd
0.2%
Dynavax Technologies Corp.
0.2%
Fortrea Holdings Inc
0.2%
Myriad Genetics, Inc.
0.2%
Biocryst Pharmaceuticals Inc.
0.2%
United Laboratories International Holdings Ltd.
0.2%
Evotec SE
0.2%
Harmony Biosciences Holdings Inc
0.2%
Xencor Inc
0.2%
Caredx Inc
0.1%
Oxford Nanopore Technologies Plc
0.1%
Certara Inc
0.1%
Pharmamar S.A.
0.1%
Recursion Pharmaceuticals Inc
0.1%
ANI Pharmaceuticals Inc
0.1%
Galapagos NV
0.1%
ImmunityBio Inc
0.1%
Neuren Pharmaceuticals Ltd
0.1%
Novavax, Inc.
0.1%
Peptron Inc.
0.1%
Schrodinger Inc
0.1%
Vir Biotechnology Inc
0.1%
ABL Bio Inc.
0.1%
Chemometec AS
0.1%
SK bioscience Co. Ltd.
0.1%
Xvivo Perfusion AB
0.1%
Zymeworks Inc
0.1%
Castle Biosciences Inc
0.1%
Keymed Biosciences Inc.
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Prothena Corporation plc
0.1%
Seegene Inc
0.1%
Adaptive Biotechnologies Corp
< 0.1%
Avid Bioservices Inc
< 0.1%
Cytek BioSciences Inc
< 0.1%
Lunit Inc
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
Relay Therapeutics Inc
< 0.1%
ST Pharm Co Ltd
< 0.1%
AbCellera Biologics Inc
< 0.1%
Arcus Biosciences Inc
< 0.1%
Axogen Inc.
< 0.1%
Polaris Group
< 0.1%
BioArctic AB
< 0.1%
Pharming Group N.V.
< 0.1%
Roche Holding AG
< 0.1%
Tobii Dynavox AB
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Eiken Chemical Co Ltd
< 0.1%
Japan Lifeline Co Ltd
< 0.1%
Quanterix Corp
< 0.1%
Simulations Plus Inc.
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
Alector Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
CompuGroup Medical SE & Co. KgaA
< 0.1%
RemeGen Co. Ltd.
< 0.1%
Stoke Therapeutics Inc
< 0.1%
AnaptysBio Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Orasure Technologies Inc.
< 0.1%
Regenxbio Inc
< 0.1%
SD Biosensor Inc.
< 0.1%
Sage Therapeutics Inc
< 0.1%
Shanghai Junshi Biosciences Co Ltd
< 0.1%
Shinpoong Pharmaceutical
< 0.1%
Takara Bio Inc.
< 0.1%
UroGen Pharma Ltd
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
Accolade Inc
< 0.1%
Fate Therapeutics Inc
< 0.1%
I‑Sens USA Inc
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Macrogenics Inc
< 0.1%
Mersana Therapeutics Inc
< 0.1%
Nevro Corp
< 0.1%
Sillajen Biotherapeutics Inc
< 0.1%
Sutro Biopharma Inc
< 0.1%
Valneva SE
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Caribou Biosciences Inc
< 0.1%
Cellivery Therapeutics Inc.
< 0.1%
Idorsia Ltd
< 0.1%
PHC Holdings Corporation
< 0.1%
uniQure N.V.
< 0.1%
Agenus Inc
< 0.1%
Nkmax Co. Ltd
< 0.1%
Peptron Inc Rights
< 0.1%
Others
0.3%
£6.16
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Our support is available Monday-Friday 5:30am to 9:00pm
and Saturday-Sunday 8:30am to 5:30pm
Why InvestEngine
Accounts
Compare
Portfolios
Calculators
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Why InvestEngine
Accounts
Portfolios
Calculators
Compare
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Facebook
Twitter
Linkedin
Instagram
Community
Visit our blog at blog.investengine.com
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.

Capital at risk